Cite
Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy.
MLA
Ren, Daixi, et al. “Correction to: Predictive Biomarkers and Mechanisms Underlying Resistance to PD1/PD-L1 Blockade Cancer Immunotherapy.” Molecular Cancer, vol. 19, no. 1, Feb. 2020, pp. 1–2. EBSCOhost, https://doi.org/10.1186/s12943-020-1144-6.
APA
Ren, D., Hua, Y., Yu, B., Ye, X., He, Z., Li, C., Wang, J., Mo, Y., Wei, X., Chen, Y., Zhou, Y., Liao, Q., Wang, H., Xiang, B., Zhou, M., Li, X., Li, G., Li, Y., Zeng, Z., & Xiong, W. (2020). Correction to: Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. Molecular Cancer, 19(1), 1–2. https://doi.org/10.1186/s12943-020-1144-6
Chicago
Ren, Daixi, Yuze Hua, Boyao Yu, Xin Ye, Ziheng He, Chunwei Li, Jie Wang, et al. 2020. “Correction to: Predictive Biomarkers and Mechanisms Underlying Resistance to PD1/PD-L1 Blockade Cancer Immunotherapy.” Molecular Cancer 19 (1): 1–2. doi:10.1186/s12943-020-1144-6.